市場調查報告書
商品編碼
1576630
電腦輔助檢測(CAD) 市場:按應用(腫瘤學、心臟病學)、按模態(乳房X 光攝影、MRI、CT、超音波)、最終用戶(醫院和診所、診斷成像中心、門診護理中心) - 直到2031 年世界預測Computer-aided Detection (CAD) Market by Application (Oncology, Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031 |
到 2031 年,電腦輔助偵測 (CAD) 市場預計將達到 15.6 億美元,2024 年至 2031 年的複合年增長率為 7.4%。
經過廣泛的二次和初步研究以及對市場情景的詳細分析,本報告對主要市場推動因素、阻礙因素、課題和機會進行了分析。這一增長是由於慢性病患病率不斷上升、人們對早期癌症診斷重要性的認識不斷提高、癌症研究投資和經費增加以及醫療保健成本增加。然而,CAD 解決方案的高成本限制了該市場的成長。
此外,CAD 解決方案的進步,例如放射科醫生對CAD 的接受度提高、癌症篩檢專案的增加以及人工智慧(AI) 和機器學習(ML) 的集成,預計將推動該市場的業務成長。然而,缺乏使用 CAD 系統所需的技術專業知識是影響市場成長的主要課題。
(註:提供上位5公司的SWOT分析)
Computer-aided Detection (CAD) Market by Application (Oncology [Breast, Lung, Colorectal, Liver], Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031
The Computer-aided Detection (CAD) market is projected to reach $1.56 billion by 2031 at a CAGR of 7.4% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditure. However, the high costs of CAD solutions restrain the growth of this market.
Furthermore, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate growth opportunities for the players operating in this market. However, the lack of technical expertise required to use CAD systems is a major challenge impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global Computer-aided Detection (CAD) market are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France).
Among all the applications studied in this report, in 2024, the oncology segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the increasing prevalence of breast cancer and the increase in breast cancer detection and awareness campaigns. Breast cancer ranks among the most prevalent cancers affecting women globally. According to the World Health Organization (WHO), 2.3 million breast cancer cases were recorded globally in 2020, and this number is expected to reach 3 million by 2040. The rising incidence of breast cancer has led to a rapid increase in the adoption of innovative technologies, such as CAD, aimed at enhancing breast cancer detection through a combination of various modalities.
Among all the imaging modalities studied in this report, in 2024, the mammography segment is expected to account for the larger share of the Computer-aided Detection (CAD) market. Computer-aided mammograms offer improved accuracy in diagnosis as the images can be zoomed in on, upgraded, or adjusted for more in-depth evaluation. Also, computer-aided mammography enables early identification of breast cancer in patients with no symptoms. These factors contribute to the segment's large share.
Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the rising prevalence of cancer, the growing number of hospitals and clinics, the availability of highly skilled professionals in hospitals and clinics, the high purchasing power of hospitals, and the increasing patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgical procedures.
An in-depth analysis of the geographical scenario of the global Computer-aided Detection (CAD) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the Computer-aided Detection (CAD) market. In the region in 2024, the U.S. is expected to account for the largest share of the Computer-aided Detection (CAD) market in North America. The large share of this regional market is attributed to the presence of major Computer-aided Detection (CAD) companies such as GE HealthCare Technologies Inc. (U.S.), and Hologic, Inc. (U.S.), increasing cancer cases, and technological advancements in cancer detection and diagnosis.
Computer-aided Detection (CAD) Market Assessment-by Application
Note: Other applications include neurology, diabetic retinopathy, and tuberculosis.
Computer-aided Detection (CAD) Market Assessment-by Imaging Modality
Note: Other imaging modalities include X-ray imaging and endoscopy.
Computer-aided Detection (CAD) Market Assessment-by End User
Computer-aided Detection (CAD) Market Assessment-by Geography
(Note: SWOT analyses of the top 5 companies will be provided.)